Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Las Vegas, Las Vegas, NV, USA.
BC Children's Hospital Research Institute and Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Environ Res. 2021 Apr;195:110825. doi: 10.1016/j.envres.2021.110825. Epub 2021 Feb 2.
Studies of prenatal per- and polyfluoroalkyl substances (PFAS) and attention deficit hyperactivity disorder (ADHD)-related behaviors in children are inconsistent.
To examine associations between maternal serum PFAS concentrations and child behavior in 241 mother-child dyads within the Health Outcomes and Measures of the Environment (HOME) Study.
We quantified perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA) in maternal serum collected during pregnancy or at delivery. We evaluated a total of 17 outcomes of child behavior using the Behavioral Assessment System for Children-2 (BASC-2) at 5 and 8 years (n = 240) and ADHD diagnostic symptoms and criteria with the Diagnostic Interview Schedule for Children-Young Child (DISC-YC) at 5 years (n = 190). We used linear mixed models and logistic regression with generalized estimating equations to assess associations between PFAS and continuous or dichotomous "at risk" BASC-2 scores; negative binomial regression to calculate incident rate ratios for counts of ADHD symptoms; and Poisson regression with robust standard errors to calculate relative risks of meeting ADHD diagnostic criteria.
Each ln-unit increase in PFOS, PFHxS, and PFNA was associated with higher BASC-2 scores and increased odds of "at-risk" scores for externalizing behaviors, including hyperactivity (PFOS: odds ratio [OR] 2.7, 95% confidence interval [CI] 1.2, 5.9; PFHxS: OR 2.5, 95% CI 1.5, 4.3; PFNA: OR 3.2, 95% CI 1.3, 8.0). PFHxS was also associated with internalizing problems (OR 2.0, 95% CI 1.1, 3.4) and somatization (OR 2.2, 95% CI 1.2, 4.0). PFOS and PFNA were significantly associated with 50-80% more DISC-YC symptoms and diagnostic criteria related to hyperactive-impulsive type ADHD. Prenatal PFNA was associated with increased risk of any-type ADHD.
Prenatal PFOS and PFNA were consistently associated with measures related to hyperactive-impulsive type ADHD across two validated assessment instruments. PFHxS was associated with increased problems with both externalizing and internalizing behaviors. No associations were noted between PFOA and child neurobehavior.
关于产前全氟和多氟烷基物质(PFAS)与儿童注意力缺陷多动障碍(ADHD)相关行为的研究结果并不一致。
在健康结果和环境测量(HOME)研究的 241 对母婴中,研究母体血清中 PFAS 浓度与儿童行为之间的关系。
我们在孕期或分娩时采集了母体血清,对其中的全氟辛烷磺酸(PFOA)、全氟辛烷磺酸(PFOS)、全氟己烷磺酸(PFHxS)和全氟壬酸(PFNA)进行了定量分析。我们使用儿童行为评估系统-2 版(BASC-2)在 5 岁和 8 岁时(n=240)评估了儿童行为的 17 个总结果,在 5 岁时(n=190)使用儿童诊断性访谈表-少年儿童版(DISC-YC)评估了 ADHD 诊断症状和标准。我们使用线性混合模型和广义估计方程进行逻辑回归,以评估 PFAS 与连续或二分“风险”BASC-2 评分之间的关系;使用负二项回归计算 ADHD 症状的发生率比;使用泊松回归和稳健标准误差计算符合 ADHD 诊断标准的相对风险。
PFOS、PFHxS 和 PFNA 的每增加一个 ln 单位,BASC-2 评分就会升高,“风险”评分也会升高,表明外化行为,包括多动,风险增加(PFOS:比值比[OR]2.7,95%置信区间[CI]1.2,5.9;PFHxS:OR 2.5,95% CI 1.5,4.3;PFNA:OR 3.2,95% CI 1.3,8.0)。PFHxS 也与内化问题(OR 2.0,95% CI 1.1,3.4)和躯体化(OR 2.2,95% CI 1.2,4.0)相关。PFOS 和 PFNA 与 DISC-YC 中 50-80%更多与多动冲动型 ADHD 相关的症状和诊断标准显著相关。PFNA 与任何类型 ADHD 的风险增加相关。
PFOS 和 PFNA 与两个经过验证的评估工具中与多动冲动型 ADHD 相关的指标都有一致的相关性。PFHxS 与外化和内化行为都存在问题相关。PFOA 与儿童神经行为之间没有关联。